DMEM (High glucose) Complete Medium
Cat.No.:PM150210B
| Item | Size | Price | Qty |
|---|---|---|---|
| 125mL×4 | Inquire |
Product Introduction
DMEM (Dulbecco's Modified Eagle Medium) was developed on the basis of MEM medium. Compared with MEM medium, the content of amino acid increased by 2 times, the content of vitamin increased by 4 times, and the content of non-essential amino acid, trace iron ion and sodium pyruvate were increased by 4 times. The glucose content of DMEM medium was originally designed as 1000 mg/L (low Glucose type), and then developed into 4500mg/L (high Glucose type), which has been widely used in cell culture. DMEM (High glucose) was widely used in fast growth, low adhesion cells, hybridoma myeloma cells, clone cells, DNA transfected transformation cells, various primary virus host cells, single cell culture and vaccine production. DMEM (High glucose) contains many kinds of amino acids, vitamins, inorganic salts and other ingredients for cell culture, but does not contain protein, lipids or any growth factors, so the product should be used with serum or serum-free additives.
Matters Need Attention
1. This product is for research use only.
2. This product is sterilized by 0.1μm filtration.
3. It is necessary to pay attention to the aseptic operation and avoid the contamination during the culture.
4. It is not suitable for long time storage at room temperature.
5. This product is a ready-to-use medium. If there is no special need, don’t add serum, penicillin and streptomycin. It can be used directly.
| Specifications | |
| Concentration | Ready-to-use |
| Volume | 125mL×4 |
| Form | Liquid |
| Bacteria Detection | Negative |
| Fungi Detection | Negative |
| Mycoplasma Detection | Negative |
| Endotoxin Content | <3 |
| pH | 7.4-7.8 |
| Green_Features | Sustainable packaging |
| Valid Period | 3 months |
| Storage Condition | 2~8℃, shading light |
| Shipping Condition | Ice bag |
Related Products
Documents
Manual
MANUAL_DMEM (High glucose) Complete Medium.pdf
MSDS
MSDS_DMEM (High glucose) Complete Medium.pdf
Citations
In vitro facilitating role of polygonatum sibiricum polysaccharide in osteogenic differentiation of bone marrow mesenchymal stem cells from patients with multiple myeloma
IF: 2.716Author：Jianqiang Zhao, Lijie Ma, Zengfeng Ni
Journal：Biotechnology Letters
DOI：10.1007/s10529-021-03125-x
Cited products： PM150210B
Doxorubicin/cisplatin co-loaded hyaluronic acid/chitosan-based nanoparticles for in vitro synergistic combination chemotherapy of breast cancer
IF: 10.723Author：Yaping Wang, Junmin Qian, Ming Yang
Journal：Carbohydrate Polymers
DOI：10.1016/j.carbpol.2019.115206
Cited products： PM150210B
A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer
IF: 10.633Author：Weijun Xu, Junmin Qian, Guanghui Hou
Journal：Acta Biomaterialia
PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer
IF: 10.633Author：Weijun Xu, Junmin Qian, Guanghui Hou
Journal：Acta Biomaterialia
A double-network poly(Nɛ-acryloyl l-lysine)/hyaluronic acid hydrogel as a mimic of the breast tumor microenvironment
IF: 10.633Author：Weijun Xu, Junmin Qian, Guanghui Hou
Journal：Acta Biomaterialia
Exosomal transfer of activated neutrophil-derived lncRNA CRNDE promotes proliferation and migration of airway smooth muscle cells in asthma
IF: 5.121Author：Xiaoyu Zhang, Zhuochang Chen, Nan Li
Journal：Human Molecular Genetics
A novel pH-sensitive targeting polysaccharide-gold nanorod conjugate for combined photothermal-chemotherapy of breast cancer
IF: 10.723Author：Guanghui Hou, Junmin Qian, Weijun Xu
Journal：Carbohydrate Polymers
Preparation, characterization, and biocompatibility evaluation of poly(Nɛ-acryloyl-l-lysine)/hyaluronic acid interpenetrating network hydrogels
IF: 10.723Author：Ning Cui, Junmin Qian, Weijun Xu
Journal：Carbohydrate Polymers
DOI：10.1016/j.carbpol.2015.09.095
Cited products： PM150210B
Ten-gene signature reveals the significance of clinical prognosis and immuno-correlation of osteosarcoma and study on novel skeleton inhibitors regarding MMP9
IF: 6.429Author：Weihang Li, Ziyi Ding, Dong Wang
Journal：Cancer Cell International
DOI：10.1186/s12935-021-02041-4
Cited products： PM150210B
miR-339-5p Inhibits Autophagy to Reduce the Resistance of Laryngeal Carcinoma on Cisplatin via Targeting TAK1
IF: 3.246Bergenin Monohydrate Attenuates Inflammatory Response via MAPK and NF-κB Pathways Against Klebsiella pneumonia Infection
IF: 5.988Author：Qihe Tang, Qingyu Wang, Zhuojian Sun
Journal：Frontiers in Pharmacology
Systematic understanding of the potential targets and pharmacological mechanisms of acteoside by network pharmacology approach
IF: 2.351Author：Yiliyasi Aisa, Kurexi Yunusi, Qian Chen
Journal：Medicinal Chemistry Research
DOI：10.1007/s00044-020-02524-5
Cited products： PM150210B
Osteoblast Jmjd3 regulates osteoclastogenesis via EphB4 and RANKL signalling
IF: 4.068LncRNA MALAT1 aggravates the retinal angiogenesis via miR-320a/HIF-1α axis in diabetic retinopathy
IF: 3.77Author：Zhen Chen, Jingying Yang, Yang Gao
Journal：Experimental Eye Research
